ArticleRadiology2023
Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats.
Open access · greenAbstract read
In one paragraph
Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 17 citations in OpenAlex.
- EPR-based Assessment of Gadolinium-based Contrast Agent Retention and Gadolinium Transchelation in Inflamed Murine Brain.Investigative radiology · 2026Article
- Real-world evidence on gadoteridol safety: A 20-year FAERS database study revealing critical adverse reaction patterns.Medicine · 2026Article
- Short- and Long-Term Effects of a Single Exposure to Gadoteric Acid in Healthy Rats-Gadolinium, Iron and Other Metal Accumulation in Kidney and Brain.International journal of molecular sciences · 2026Article
- Zwitterionic [Gd-(DOTA)] MRI Probes: Influence of Sulfobetaine Linker Length on Relaxivity.ACS omega · 2026Article
- Zwitterionic Mn(III)-Tetraphenyl Porphyrins: Water-Soluble MRI Contrast Agents with High Relaxivity.ChemMedChem · 2026Article
- Synthesis and Characterization of a Novel Biphenol-Based Gadolinium Complex for Encapsulation in Human Red Blood Cells.International journal of molecular sciences · 2026Article
- Gadolinium Nanoparticles: Emerging Platforms Beyond Imaging for Drug Delivery and Theranostics.Pharmaceutics · 2026Review
- Pharmacokinetics, Excretion, and Organ Distribution of the Novel Gadolinium-Based MRI Contrast Agent Gadoquatrane in Female Cynomolgus Monkeys.Investigative radiology · 2025Article
- Gadolinium toxicity: mechanisms, clinical manifestations, and nanoparticle role.Archives of toxicology · 2025Review
- Ferrocene-Functionalized Black Phosphorus Nanoplatform Enables Targeted and Prolonged MRI Visualization of Atherosclerotic Plaques.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Development of uMUC-1 Targeted NEMO Particles with pH-Activatable MRI Signals for Enhanced Detection of Malignant Breast Cancer Cells.ACS applied bio materials · 2025Article
- Early endolysosomal dysfunction is a contributing factor to gadolinium-based contrast agent mouse renal proximal tubule epithelial cell injury.Cell biology and toxicology · 2025Article
- Gadopiclenol: A q = 2 Gadolinium-Based MRI Contrast Agent Combining High Stability and Efficacy.Investigative radiology · 2025Article
- Study of Interactions Between Gadolinium-Based Contrast Agents and Collagen by Taylor Dispersion Analysis and Frontal Analysis Continuous Capillary Electrophoresis.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Impact of dietary zinc on stimulated zinc secretion MRI in the healthy and malignant mouse prostate.Npj imaging · 2024Article
Corrections and comments
- Commented on by
Authors and funding
16 authors at 3 institutions in 2 countries.
Mariane Le FurFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0001-8680-0903
Brianna F MoonFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0003-0642-0551
Iris Y ZhouFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0002-4351-7398
Samantha ZygmontFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Avery BoiceFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0009-0004-2722-2524
Nicholas J RotileFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Ilknur AyFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0001-9558-742X
Pamela PantazopoulosFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Adam S FeldmanFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Ivy A RosalesFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Ira Doressa Anne L HowFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
David Izquierdo-GarciaFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0003-0763-8827
Lida P HaririFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Andrei V AstashkinFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0002-7957-3674
Brian P JacksonFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).ORCID 0000-0003-2311-2972
Peter CaravanFrom the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., D.I.G., P.C.), Department of Urology (A.S.F.), and Department of Pathology (I.A.R., I.D.A.L.H., L.P.H.), Massachusetts General Hospital and Harvard Medical School, 149 13th St, Charlestown, MA 02129; Institute for Innovation in Imaging, Massachusetts General Hospital, Charlestown, Mass (M.L.F., B.F.M., I.Y.Z., S.Z., A.B., N.J.R., I.A., P.P., P.C.); Harvard-MIT Health Sciences and Technology, Cambridge, Mass (D.I.G.); Bioengineering Department, Universidad Carlos III de Madrid, Madrid, Spain (D.I.G.); Department of Chemistry and Biochemistry, University of Arizona, Tucson, Ariz (A.V.A.); and Trace Element Analysis Laboratory, Dartmouth College, Hanover, NH (B.P.J.).
Harvard University · USDartmouth College · USUniversity of Arizona · US
Funding
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3MLaying the Groundwork for Web-based Elemental Imaging Software: The MicroAnalysis ToolkitR24GM141194 · NIGMS · DARTMOUTH COLLEGE · PI Brian P Jackson · 2021 to 2026
$3.1MQuantification of whole-body distribution and speciation of gadolinium-based contrast agents by Y-86 PET/MRIR00EB030602 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI LE FUR, MARIANE · 2023 to 2025
$738kQuantitative MRI-PET Imaging of Pulmonary FibrosisK25HL148837 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ZHOU, IRIS YUWEN · 2020 to 2023
$686kLaser Ablation-ICPTOF for fast multi-element imaging of biomedical samplesS10OD032352 · OD · DARTMOUTH COLLEGE · PI JACKSON, BRIAN P · 2022 to 2022
$663kInductively Coupled Plasma Mass SpectrometerS10OD032138 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2022 to 2022
$598kHPLC-ICP-MS SystemS10OD010650 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2013 to 2013
$371kQuantification of whole-body distribution and speciation of gadolinium-based contrast agents by Y-86 PET/MRIK99EB030602 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI LE FUR, MARIANE · 2021 to 2022
$186kNCI NIH HHS P30 CA023108NHLBI NIH HHS K25 HL148837NIBIB NIH HHS K99 EB030602NIBIB NIH HHS R00 EB030602NIGMS NIH HHS R24 GM141194NIH HHS S10 OD010650NIH HHS S10 OD032138NIH HHS S10 OD032352
Abstract
Background Gadolinium retention has been observed in organs of patients with normal renal function; however, the biodistribution and speciation of residual gadolinium is not well understood. Purpose To compare the pharmacokinetics, distribution, and speciation of four gadolinium-based contrast agents (GBCAs) in healthy rats using MRI, mass spectrometry, elemental imaging, and electron paramagnetic resonance (EPR) spectroscopy. Materials and Methods In this prospective animal study performed between November 2021 and September 2022, 32 rats received a dose of gadoterate, gadoteridol, gadobutrol, or gadobenate (2.0 mmol/kg) for 10 consecutive days. GBCA-naive rats were used as controls. Three-dimensional T1-weighted ultrashort echo time images and R2* maps of the kidneys were acquired at 3, 17, 34, and 52 days after injection. At 17 and 52 days after injection, gadolinium concentrations in 23 organ, tissue, and fluid specimens were measured with mass spectrometry; gadolinium distribution in the kidneys was evaluated using elemental imaging; and gadolinium speciation in the kidney cortex was assessed using EPR spectroscopy. Data were assessed with analysis of variance, Kruskal-Wallis test, analysis of response profiles, and Pearson correlation analysis. Results For all GBCAs, the kidney cortex exhibited higher gadolinium retention at 17 days after injection than all other specimens tested (mean range, 350-1720 nmol/g vs 0.40-401 nmol/g;
Indexed as
Contrast MediaOrganometallic CompoundsAnimalsBrainGadoliniumGadolinium DTPAHeterocyclic CompoundsHumansMagnetic Resonance ImagingProspective StudiesRatsTissue DistributionContrast MediaGadoliniumGadolinium DTPAgadoteridolHeterocyclic CompoundsOrganometallic Compounds
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.